Literature DB >> 9011463

Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability.

B Yacyshyn1, J Meddings, D Sadowski, M B Bowen-Yacyshyn.   

Abstract

Increased intestinal permeability and the CD45RO isoform expression of the leukocyte common antigen on peripheral blood CD20+ B cells are found in Crohn's disease. Others have observed that multiple sclerosis (MS) patients may have an increased risk of coacquisition of Crohn's disease. The aim of this study was to identify an association between these diseases using peripheral blood CD45 isoform expression and intestinal permeability in MS. Lactulose/mannitol permeability and peripheral blood CD20+ B cell CD45RO expression were defined in healthy controls, MS patients, and patients coincidentally affected by MS and Crohn's or MS and ulcerative colitis (UC). Five of 20 MS patients had increased intestinal permeability, a finding not previously reported. High levels of CD45RO were found on circulating CD20+ B cells from patients with MS. This has not been reported previously in MS and is found in very few other conditions. Eight patients with coincident MS and Crohn's disease or MS and UC were studied. Coincident MS and UC patients expressed CD45RO on CD20+ B cells, a finding not identified in UC patients alone. A subgroup of MS patients has increased intestinal permeability. These patients express CD45RO CD20+ B cells, also found in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9011463     DOI: 10.1007/bf02100148

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

Review 1.  T-cell recognition of myelin basic protein.

Authors:  K W Wucherpfennig; H L Weiner; D A Hafler
Journal:  Immunol Today       Date:  1991-08

Review 2.  The molecular biology of autoimmune disease.

Authors:  A G Demaine
Journal:  Immunol Today       Date:  1989-11

3.  Possible familial association of multiple sclerosis and inflammatory bowel disease.

Authors:  G Y Minuk; R M Lewkonia
Journal:  N Engl J Med       Date:  1986-02-27       Impact factor: 91.245

4.  Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.

Authors:  J B Sun; T Olsson; W Z Wang; B G Xiao; V Kostulas; S Fredrikson; H P Ekre; H Link
Journal:  Eur J Immunol       Date:  1991-06       Impact factor: 5.532

5.  Transition in CD45 isoform expression during differentiation of normal and abnormal B cells.

Authors:  G S Jensen; S Poppema; M J Mant; L M Pilarski
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

6.  Leucocyte common antigen expression on T cells in normal and inflamed human gut.

Authors:  J Harvey; D B Jones; D H Wright
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

7.  Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis.

Authors:  B R Yacyshyn
Journal:  Immunol Cell Biol       Date:  1993-08       Impact factor: 5.126

8.  Purification of primary antibodies of the myelin basic protein antibody cascade from multiple sclerosis patients. Immunoreactivity studies with homologous and heterologous antigens.

Authors:  K G Warren; I Catz
Journal:  Clin Invest Med       Date:  1992-02       Impact factor: 0.825

9.  Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system.

Authors:  R A Sobel; M E Mitchell; G Fondren
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

10.  CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability.

Authors:  B R Yacyshyn; J B Meddings
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

View more
  37 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  What caused the increase of autoimmune and allergic diseases: a decreased or an increased exposure to luminal microbial components?

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

3.  Can Our Guts Tell Us Anything About MS?

Authors:  Carlos R Camara-Lemarroy
Journal:  J Neuroimmune Pharmacol       Date:  2019-02-15       Impact factor: 4.147

4.  MyD88 adaptor-like (Mal) functions in the epithelial barrier and contributes to intestinal integrity via protein kinase C.

Authors:  S C Corr; E M Palsson-McDermott; I Grishina; S P Barry; G Aviello; N J Bernard; P G Casey; J B J Ward; S J Keely; S Dandekar; P G Fallon; L A J O'Neill
Journal:  Mucosal Immunol       Date:  2013-04-24       Impact factor: 7.313

Review 5.  Leaky gut and autoimmune diseases.

Authors:  Alessio Fasano
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

6.  Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila.

Authors:  Michael Rera; Rebecca I Clark; David W Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-12       Impact factor: 11.205

Review 7.  Intestinal permeability defects: is it time to treat?

Authors:  Matthew A Odenwald; Jerrold R Turner
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-12       Impact factor: 11.382

Review 8.  Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.

Authors:  Craig Sturgeon; Alessio Fasano
Journal:  Tissue Barriers       Date:  2016-10-21

Review 9.  Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis.

Authors:  M C Buscarinu; S Romano; R Mechelli; R Pizzolato Umeton; M Ferraldeschi; A Fornasiero; R Reniè; B Cerasoli; E Morena; C Romano; N D Loizzo; R Umeton; M Salvetti; G Ristori
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 10.  The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).

Authors:  Gerwyn Morris; Michael Berk; Piotr Galecki; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-09-26       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.